A schwannoma is a slow-growing, typically benign tumor that develops from Schwann cells, the cells responsible for insulating nerves throughout your body. When one forms near the brain, it most commonly grows on the vestibular nerve, which connects the inner ear to the brainstem. This type, called a vestibular schwannoma (or acoustic neuroma), accounts for the vast majority of schwannomas found in the skull. Under the current WHO classification, schwannomas are classified as low-grade tumors, meaning they rarely become cancerous.
How Schwannomas Form
Schwann cells wrap around nerve fibers in layers, creating a protective sheath that helps electrical signals travel efficiently. When the genetic instructions controlling Schwann cell growth go wrong, these cells can multiply into a solid mass along the nerve. Unlike some other nerve tumors that contain a mix of cell types, schwannomas are composed entirely of neoplastic Schwann cells.
The key genetic event behind most schwannomas is the loss of a protein called merlin, which normally acts as a brake on cell growth. When merlin stops functioning, growth-promoting signals inside the cell go unchecked, and a tumor gradually forms. This can happen spontaneously in one location, or it can be driven by an inherited condition.
The Link to NF2
Most schwannomas occur as a single, isolated tumor with no clear cause. However, a genetic condition called NF2-related schwannomatosis significantly raises the risk. People with this condition carry a mutation on chromosome 22 in the gene that produces merlin. It’s inherited in an autosomal dominant pattern, meaning a single copy of the altered gene from one parent is enough to cause the disorder.
The hallmark of NF2-related schwannomatosis is bilateral vestibular schwannomas, tumors on the hearing and balance nerves on both sides of the head. About 88% of people with this condition develop bilateral tumors. Sporadic (non-inherited) vestibular schwannomas, by contrast, almost always appear on one side only.
Symptoms to Recognize
Because vestibular schwannomas grow on the nerve bundle connecting the inner ear to the brain, the earliest symptoms tend to involve hearing and balance. The most common pattern is one-sided or noticeably asymmetric hearing loss that develops gradually over months or years. Tinnitus, a persistent ringing or buzzing in one ear, frequently accompanies the hearing change. Dizziness and a subtle loss of balance are also early signs.
As the tumor enlarges, it can press against nearby structures. A schwannoma that grows large enough may compress the facial nerve, causing numbness or weakness on one side of the face. In rare cases where a tumor becomes very large, it can press on the brainstem and interfere with coordination or even the flow of cerebrospinal fluid, creating more serious neurological symptoms. Most schwannomas are caught well before reaching that stage.
How Schwannomas Are Diagnosed
MRI is the primary tool for identifying schwannomas. On imaging, these tumors appear as well-defined masses that light up brightly after a contrast dye is injected. A vestibular schwannoma often produces a characteristic “ice cream cone” appearance: a round mass sitting outside the skull base with a smaller extension reaching into the internal ear canal, like a scoop on a cone.
Radiologists also look for several features that distinguish schwannomas from more aggressive tumors. A thin rim of fat surrounding the mass (the split fat sign), a bright border on certain imaging sequences, a smooth shape without deep irregular lobes, and the absence of significant swelling in surrounding tissue all point toward a benign schwannoma rather than something more concerning. A visible nerve entering and exiting the mass is another strong clue.
Watch and Wait
Not every schwannoma needs immediate treatment. Many are discovered incidentally or when they’re still small, and a common first step is observation with periodic MRI scans. The goal is to track whether the tumor is actually growing. Most centers define meaningful growth as a change of 2 millimeters or more in the tumor’s largest dimension between scans. Some also use volumetric analysis, which calculates the tumor’s three-dimensional size for a more precise measurement.
For people with small tumors, stable hearing, and minimal symptoms, observation can continue for years. If scans show consistent growth or symptoms worsen, the conversation shifts to active treatment.
Surgery
When a schwannoma needs to be removed, surgeons choose from several approaches depending on the tumor’s size, location, and whether preserving hearing is realistic. The four main surgical routes for vestibular schwannomas are the translabyrinthine, retrolabyrinthine, retrosigmoid, and middle cranial fossa approaches. Each accesses the tumor from a slightly different angle relative to the ear and skull base.
The facial nerve runs extremely close to where these tumors grow, so protecting it is a central concern during surgery. Anatomic preservation of the facial nerve, meaning it remains physically intact, is achieved in about 97% of cases. Functional preservation is a higher bar: roughly 77% of patients have good facial nerve function (near-normal movement) one year after surgery. In the small number of cases where the nerve is disrupted during the operation, surgeons can perform an immediate nerve repair to restore some function over time.
Hearing outcomes depend heavily on tumor size and how much hearing remains before surgery. Smaller tumors offer a better chance of hearing preservation, which is one reason early detection matters.
Focused Radiation
Stereotactic radiosurgery delivers a highly focused beam of radiation to the tumor while sparing surrounding brain tissue. Despite the name, it involves no incision. It’s commonly used for small to medium schwannomas, particularly in patients who want to avoid open surgery or who have health conditions that make surgery riskier.
Typical treatment protocols use a single session delivering around 12 to 13 Gy of radiation, or the dose is spread across three to five sessions. With current dosing, tumor control rates at three to five years exceed 91%. Spreading the dose across multiple sessions can push control rates even higher: 94% with three sessions and 97% with five. These multi-session approaches also help reduce the risk of damage to nearby cranial nerves.
Radiosurgery doesn’t remove the tumor. Instead, it stops or dramatically slows growth, and in some cases the tumor gradually shrinks over the following years. Patients still need periodic MRI monitoring afterward.
Life After Treatment
Because schwannomas are benign, the long-term outlook after successful treatment is generally very good. Recurrence after complete surgical removal is uncommon, and radiosurgery maintains tumor control in the vast majority of patients for years. The main lasting effects relate to the nerves the tumor was pressing on. Some degree of hearing loss on the affected side is common, and balance problems can take weeks to months to fully compensate for as the brain adjusts.
For people with NF2-related schwannomatosis, monitoring is a longer commitment. New schwannomas can develop on other nerves over time, so ongoing surveillance with regular imaging is a standard part of care throughout life.